Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Donor Selection

In: The European Blood and Marrow Transplantation Textbook for Nurses: Under the Auspices of EBMT [Internet]. Cham (CH): Springer; 2018. Chapter 3.
.
Affiliations
Free Books & Documents
Review

Donor Selection

Mairéad Níchonghaile.
Free Books & Documents

Excerpt

Allogeneic haematopoietic stem cell transplant (HSCT) is the treatment of choice for a variety of malignant and non-malignant disorders. The aim of HSCT is to replace the patient’s haematopoiesis with that taken from a donor, and a prerequisite is the identification of a suitable donor. It is an intense and demanding process and puts considerable strain on both recipients and donors. The choice of donor has an impact on the transplantation process from scheduling to outcome. There are several common donor issues whether the donor is related or unrelated including eligibility, confidentiality, informed consent and right to refuse consent.

PubMed Disclaimer

References

    1. Apperley J, Carreras E, Gluckman E, Masszi T. Haematopoeitic stem cell transplantation. 6th revised ed. 2012.
    1. Gragert L, et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. N Engl J Med. 2014;371(4):339–48. - PMC - PubMed
    1. Hutt D, Nehari M, Munits-Shenkar D, Akalay Y, Toren A, Bielorai B. Haematopoietic stem cell donation: psychological perspectives of paediatric sibling donors and their parents. Bone Marrow Transplant. 2015;50:1–6. - PubMed
    1. Kisch, AM. Allogeneic stem cell transplant. Patient and sibling donors perspective. Malmo University. 2015.
    1. Kollman C, Howe CW, Ansetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors. Blood. 2001;98:2043–51. - PubMed

LinkOut - more resources